Skip to main content
CDC Website

TB

Nontuberculous Mycobacteria (NTM)

This handout describes nontuberculous mycobacteria (NTM), clinical manifestations, NTM diagnosis, treatment, and action required. The handout also includes 2019 data from the Virginia Department of Health TB Program and links to additional information.

COVID-19 and Tuberculosis

The handout provides information on the similarities and differences between COVID-19 and TB, lists who is at higher risk for TB, and includes additional recommendations. 

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

TB Personal Stories - Kate

This story highlights the personal experiences of a Tuberculosis (TB) survivor who was diagnosed and treated for TB disease. The survivor details the challenges of a lengthy hospital stay, her worries over how TB medicines would affect her pregnancy and baby, and her work as an advocate since recovering from TB.

Five things to know about tuberculosis as it surfaces in Maine and North Carolina

Recent weeks have seen a handful of new Tuberculosis (TB) cases reported in states including Maine, North Carolina and California. While TB is rare in the U.S., even a single active case warrants attention. This article provides an overview of what TB is & how it spreads. TB is caused by a bacterium (Mycobacterium tuberculosis) that typically attacks the lungs, forming lesions called “tubercles,” and can destroy lung tissue — severe disease can lead to respiratory failure.